Preparation, characterization, and antitumor efficacy of biodegradable poly(lactic acid) methotrexate implantable films

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 4, Issue 2, 1997, Pages 101-106

  Singh, U V ^a   Pandey, S ^a   Umadevi, P ^b   Udupa, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Biodegradable; Drug release; Films; Methotrexate; Poly(lactic acid)

Indexed keywords

METHOTREXATE; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODEGRADATION; CANCER GRAFT; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FILM; IMPLANT; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA 180; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

EID: 0030958449     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549709051880     Document Type: Article

References (39)

1. Asano, M., Fukuzaki, H., Yoshida, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, M., Kawatiarrada, U., and Suzuki K. 1991. In vivo controlled release of luteinizing hormone-releasing hormone against from poly(D,L-lactic acid) formulations of varying degradation pattern. Int. J. Pharm. 67, 67-77.
2. Azmin, M. N., Florence, A. T., Handjani-Vila, R. M., Stuart, J. F. B., Vanlereberghe, G., and Whittaker, J. S. 1985. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J. Pharm. Pharmacol. 37, 237-242.
3. Bhagat, H. R., Hollenbeck, R. G., Pande, P. G., Bogdansky, S., Fait, C. D., and Rock, M. 1994. Preparations and evaluation of methotrexate loaded biodegradable polyanhydride microspheres. Drug. Dev. Ind. Pharm. 20, 1725-1737.
4. Bodmeier, R., Oh, K. H., and Chen, H. 1989. The effect of addition of low molecular weight on poly(D,L-lactide) drug release from biodegradable poly(dl-lactide) drug delivery systems. Int. J. Pharm. 51, 1-8.
5. Chakrabarti, S. G., and Bernstein, I. A. 1969. A simplified fluorometric method for determination of plasma methotrexate. Clin. Chem. 15, 1157-1161.
6. Chatelut, E., Suh, P., and Kim, S. 1994. Sustained release of methotrexate for intracavitary chemotherapy. J. Pharm. Sci. 63, 429-432.
7. Chien, Y. W. 1982. Implantable controlled drug delivery system. In Novel Drug Delivery Systems, 311-407. New York: Marcel Dekker.
8. Chu, C. C. 1982. The effect of pH on the in vitro degradation of poly(glycolide lactide) copolymer absorbable sutures. J. Biomed. Mater. Res. 16, 117-124.
9. Danckwerts, M., and Fassihi, A. 1991. Implantable controlled release drug delivery system: A review. Drug. Dev. Ind. Pharm. 17, 1465-1502.
10. Deasy, P. B., Finan, M. P., Klatt, P. R., and Hornykiewytsch, T. 1993. Design and evaluation of a biodegradable implant for improved delivery of oestradiol-17β to steers. Int. J. Pharm. 89, 251-259.
11. Fredericks, R. J., and Melveger, A. J. 1984. Morphological and structural changes in a copolymer of glycolide occurring as a result of hydrolysis. J. Polym. Sci. Polym. Phys. Ed. 22, 57-66.
12. Fuzuki, H., Yoshida, M., Asano, M., and Kamakura, M. 1989. Synthesis of co-poly(DL-lactic acid) with relatively low molecular weight and in vitro degradation. Eur. Polym. J. 25, 1019-1026.
13. Ghosh, M. K., Dane, K. O., and Mitra, A. K. 1988. Preparation and characterization of methotrexate-immunoglobulin conjugates. Drug Des. Delivery 4, 13-25.
14. Gibaldi, M., and Perrier, D. 1982. Pharmacokinetics, 2nd ed. New York: Marcel Dekker.
15. Hay, D. L., Von Fraunhofer, J. A., Chegini, N., and Masterson, B. J. 1988. Locking mechanism strength of absorbable ligating devices. J. Biomed. Mater. Res. 22, 179-185.
16. Higuchi, T. 1963. Mechanism of sustained action medication. J. Pharm. Sci. 52, 1145-1149.
17. Juni, K., Ogata, J., Matsui, N., Kubota, M., and Nakano, M. 1985. Control of release of bleomycin from polylactic acid microspheres by additives. Chem. Pharm. Bull. 33, 1609-1614.
18. Kim, C. K., and Oh, Y. K. 1988. Development of hydrophilic human serum albumin microspheres using a drug-albumin conjugate. Int. J. Pharm. 47, 163-169.
19. Langer, R. 1981. New method of drug delivery. Science 240, 1527-1533.
20. Law, S. L., and Lin, F. M. 1991. Release of methotrexate from microsphere-in-oil-water emulsion. Drug. Dev. Ind. Pharm. 17, 919-930.
21. LeCorre, P., LeGuevello, P., Gajan, V., Chevanne, F., and LeVerge, R. 1994. Preparation and characterization of bupivacaine loaded poly lactide and poly lactide-co-glycolide microspheres. Int. J. Pharm. 107, 41-49.
22. Leong, K. W., and Langer, R. 1987. Polymeric controlled delivery. Adv. Drug Delivery Rev. 1, 199-233.
23. Leung, S. S., Lee, V. H. L., and Robinson, J. R. 1987. Parenteral products. In Controlled Drug Delivery-Fundamentals and Applications, ed. J. R. Robinson and V. H. L. Lee, 433-480. New York: Marcel Dekker.
24. Makino, K., Arakawa, M., and Kondo, T. 1985. Preparation and in vitro degradation properties of polylactide microcapsules. Chem. Pharm. Bull. 33, 1195-1201.
25. Narayani, R., and Rao, K. P. 1993. Preparation, characterization and in vitro stability of hydrophilic gelatin microspheres using a gelatin-methotrexate conjugate. Int. J. Pharm. 95, 85-91.
26. Narayani, R., and Rao, K. P. 1996. Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate. Int. J. Pharm. 128, 261-268.
27. Nias, A. H. W. 1990. Radiation biology. In Treatment of Cancer, ed. K. Sikora and K. E. Halnan, 53-55. London: Chapman & Hall Medical.
28. Omelczuk, M. O., and McGinity, J. W. 1992. The influence of polymer glass transition temperature and molecular weight on drug release from tablets containing poly(DL-lactic acid). Pharm. Res. 9, 26-32.
29. Pitt, C. G., Jeffcoat, A. R., Zweidinger, R. A., and Schindler, A. 1979. Sustained drug delivery systems. I. The permeability of poly(ε-caprolactone), poly(DL-lactic acid), and their copolymers. J. Biomed. Mater. Res. 13, 497-507.
30. Ruiz, J. M., and Benoit, J. P. 1991. In vivo peptide release from poly(dl-lactic acid co-glycolic acid) polymers 50/50 microspheres. J. Controlled Release 16, 177-186.
31. Sampath, S. S., Garvin, K., and Robinson, D. H. 1992. Preparation and characterization of bio-degradable poly (L-lactic acid) gentamicin delivery systems. Int. J. Pharm. 78, 165-174.
32. Samuelov, Y., Donbrow, M., and Friedman, M. 1979. Sustained release of drugs from ethylcellulose polyethylene glycol films and kinetics of drug release. J. Pharm. Sci. 68, 325-329.
33. Shen, W. C., and Ryser, J. P. H. 1979. Poly(L-lysine) and poly(D-lysine) conjugates of methotrexate: Different inhibitory effect on drug resistant cells. Mol. Pharmacol. 16, 614-622.
34. Shilong, C., Taifu, L., Zhenhua, W., Jue, Z., Kangmei, H., Weiqiang, Y., and Xiaolan, S. 1989. DNA flow cyometric analysis of human nasopharyngeal carcinoma in nude mice. Int. J. Radiat. Oncol. Biol. Phys. 16, 343-350.
35. Thies, C. 1981. Biodegrdable polymers for parenteral administration. Int. J. Pharm. Tech. Prod. Manuf. 2, 25-32.
36. Tice, T. R. 1985. Long acting biodegradable steroid microcapsule for parenteral administration. Polym. Prepr. 26, 198-199.
37. Wise, D. L., Trantolo, D. J., Marino, R. T., and Kitchell, J. P. 1987. Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines. Adv. Drug. Delivery Rev. 1, 19-39.
38. Yolles, S., Leafe, T. D., and Meyer, F. J. 1975. Timed release depot for anticancer agents. J. Pharm. Sci. 64, 115-116.
39. Zimmerman, M., Parsons, J. R., and Alexander, H. 1987. The design and analysis of a laminated partially degradable composite bone plate for fracture fixation. J. Biomed. Mater. Res. Appl. Biomater. Suppl. 21, 345-361.